A model of β-cell mass, insulin, and glucose kinetics: Pathways to diabetes

Journal of Theoretical Biology

Volumn 206, Issue 4, 2000, Pages 605-619

  Topp, Brian ^a   Promislow, Keith ^a   Devries, Gerda ^b   Miura, Robert M ^c   Finegood, Diane T ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; CELL GROWTH; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; KINETICS; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0034699781     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2000.2150     Document Type: Article

References (59)

1. The reliability of rates of glucose appearance in vivo calculated from constant tracer infusions
2. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells
3. Insulin resistance in obesity: Metabolic mechanisms and measurement methods
4. Quantitative estimation of insulin sensitivity
5. Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose
6. Assessment of insulin sensitivity in vivo
7. Neogenesis vs. apoptosis as main components of pancreatic beta-cell mass changes in glucose-infused normal and mildly diabetic adult rats
8. Pharmacokinetic approach to the estimation of hepatic removal of insulin
9. Glucose disposal is not proportional to plasma glucose level in man
10. Perspective: Postnatal pancreatic β-cell growth
11. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion
12. A second pathway for regeneration of adult exocrine and endocrine pancreas: A possible recapitulation of embryonic development
13. Actively synthesizing β-cells secrete preferentially after glucose stimulation
14. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation
15. Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: Is a divorce possible?
16. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics
17. On a simple model of insulin secretion
18. A compartmental model to quantitate in vivo glucose transport in the human forearm
19. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes
20. Glucose-induced insulin secretion by perfused pancreas of 2- and 12-mo-old Fischer 344 rats
21. Pathogenesis of NIDDM. A balanced overview
22. Dyslipidaemia and obesity
23. Glucose and tolbutamide induce apoptosis in pancreatic β-cells
24. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets
25. Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated new born rats
26. Application of the minimal model of glucose kinetics
27. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates
28. Dynamics of β-cell mass in the growing rat pancreas estimation with a simple mathematical model
29. Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans
30. Glucose promotes survival of rat pancreatic β-cells by activating synthesis of proteins which suppress a constitutive apoptotic program
31. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent
32. Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia
33. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding
34. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited
35. Natural history of β-cell dysfunction in NIDDM
36. Increased proinsulin/insulin ratio in pancreas extracts of hyperglycmic rats
37. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia
38. Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation
39. A new method for the measurement in vitro of pancreatic insulin secretion
40. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
41. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
42. Roles of insulin resistance and β-cell dysfunction in dexamethasone-induced diabetes
43. Glucose toxicity: The implications of hyperglycemia in the pathophysiology of diabetes mellitus
44. Understanding 'insulin resistance': Both glucose resistance and insulin resistance are required to model human diabetes
45. Heterogeneity and contact-dependent regulation of hormone secretion by individual β-cells
46. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic β-cells
47. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth
48. Fatty acid-induced β-cell apoptosis: A link between obesity and diabetes
49. Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice
50. Influence of glucose loading and of injected insulin on hepatic glucose output
51. The role of glucose in the in-vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic β-cells
52. Report of the expert committee on the diagnosis and classification of diabetes mellitus
53. Markedly reduced β-cell function does not result in insulin resistance in islet autografted dogs
54. Quantitative estimation of β-cell sensitivity to glucose in the intact organism: A minimal model of insulin kinetics in the dog
55. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat
56. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
57. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes
58. Free fatty acids impair hepatic insulin extraction in vivo
59. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats